Navigation Links
March of Dimes awards $250,000 to researcher who identified heart disease genes
Date:3/8/2013

WASHINGTON, D.C., March 8, 2013 A scientist whose research suggests potential cures for heart disease and treatment for heart defects the most common type of birth defects will receive the 2013 March of Dimes Prize in Developmental Biology.

About 35,000 infants (1 out of every 125) are born with heart defects each year in the United States. Heart defects are among the most common birth defects and are the leading cause of birth defect-related infant deaths, accounting for about 25 percent of infant deaths.

Eric N. Olson, Ph.D., professor and chair of Molecular Biology at The University of Texas Southwestern Medical Center, Dallas, has discovered pivotal genes and regulatory pathways that govern the development, disease and regeneration of the heart and other muscles. His discoveries help explain how heart formation occurs and have provided new ideas for ways to treat heart disease in children and adults.

"Heart defects affect about one percent of newborns and all of these cardiac birth defects are caused by abnormalities that occur during development," said Joe Leigh Simpson, MD, senior vice president for Research and Global Programs at the March of Dimes. "Dr. Olson's work has portrayed a detailed genetic model for heart development that provides a framework for how these genes function in normal and abnormal heart development. His work will surely lead to new ways to treat and prevent cardiac defects in infants as well as in adults."

Dr. Olson attended Wake Forest University, receiving a B.A. in chemistry and biology and a Ph.D. in biochemistry. After postdoctoral training at Washington University School of Medicine, he assumed his first faculty position in 1984 at MD Anderson Cancer Center, where he became Professor and Chair of Biochemistry and Molecular Biology in 1991. In 1995, he founded the Department of Molecular Biology at UT Southwestern.

Dr. Olson will receive the Prize at a gala black-tie dinner and ceremony at the Willard Intercontinental in Washington, D.C. He also will deliver the 18th Annual March of Dimes Prize Lecture titled: "The Molecular Circuitry of Heart Development, Disease and Repair" at the Walter E. Washington Convention Center during the Pediatric Academic Societies annual meeting. CBS sportscaster Greg Gumbel, member of the March of Dimes national Honorary Board of Trustees, is expected to host the award ceremony.

Individuals who receive the March of Dimes Prize are leaders in the field of developmental biology. Their pioneering research offers hope for prevention and treatments for some of the most serious birth defects and other human diseases.

The March of Dimes Prize in Developmental Biology has been awarded annually since 1996 to investigators whose research has profoundly advanced the science that underlies the understanding of birth defects. The March of Dimes Foundation created the Prize as a tribute to Dr. Jonas Salk shortly before his death in 1995. Dr. Salk received Foundation support for his work on the first safe and effective polio vaccine. The prize is a cash award of $250,000 and a silver medal in the design of the Roosevelt dime, honoring of President Franklin D. Roosevelt, March of Dimes founder.

In its 18-year history, the March of Dimes Prize in Developmental Biology has been the crowning glory of a distinguished research career or a stepping stone on the path toward future honors for researchers. In fact, six past March of Dimes Prize recipients have gone on to win a Nobel Prize.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert  

Related biology news :

1. Genetics Society of Americas Genetics journal highlights for March 2013
2. March of Dimes funds new preterm birth research
3. March story tips
4. March of the pathogens: Parasite metabolism can foretell disease ranges under climate change
5. Southern insect scientists to meet in Baton Rouge in March
6. As climate warms, bark beetles march on high-elevation forests
7. March of Dimes awards $250,000 prize to 2 scientists who pioneered advances in skin disorders
8. UTMB scientist awarded $150,000 by March of Dimes
9. AGU journal highlights for March 29, 2012
10. Story tips From the Department of Energys Oak Ridge National Laboratory, March 2012
11. MARC Travel Awards announced for Immunohistochemistry and Microscopy (IHCM) Short Course 2013
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
March of Dimes awards $250,000 to researcher who identified heart disease genes
(Date:11/21/2016)...   Neurotechnology , a provider of high-precision ... that the MegaMatcher On Card fingerprint matching algorithm ... NIST Minutiae Interoperability Exchange (MINEX) III ... of the evaluation protocol. The ... fingerprint templates used to establish compliance of template ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:6/22/2016)... 2016  The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... 2016 , ... DrugDev believes the only way to achieve real ... All three tenets were on display at the 2nd Annual DrugDev User Summit (hosted ... CRO and site organizations to discuss innovation and the future of clinical research. ...
(Date:12/2/2016)... 2, 2016 The immunohistochemistry (IHC) market ... a CAGR of 7.3% during the forecast period of 2016 to ... laboratories segment accounted for the largest share of immunohistochemistry (IHC) market, ... , ... immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies and ...
(Date:11/30/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... excited to announce the formation of EyGen, Ltd. ... ophthalmology assets through proof of concept. EyGen,s lead ... Portage Pharmaceuticals Limited and being developed for topical ... anterior segment diseases. This agent has the potential ...
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 Novogene ... services and solutions with cutting edge next-generation sequencing (NGS) ... a USD $75 Million [515 Million RMB] B round ... Capital Management ( Shenzhen ) Co., Ltd. ... Innovation") and Shanghai Sigma Square Investment Center LP ("Sigma ...
Breaking Biology Technology: